Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma.

Salem, Hesham; Abdelaziz, Amany; Galal, Mariam; Hussien, Maha; Emad, Nadeen; Batekh, Asmaa E; Karem, Mohamed; Moukhtar, Deena A

Salem, Hesham; Abdelaziz, Amany; Galal, Mariam; Hussien, Maha; Emad, Nadeen; Batekh, Asmaa E; Karem, Mohamed; Moukhtar, Deena A.

Afiliação

Salem H; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt. Electronic address: h_salem_eg@yahoo.com.
Abdelaziz A; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Galal M; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Hussien M; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Emad N; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Batekh AE; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Karem M; Faculty of Pharmacy, Deraya University, New Minia, Egypt.
Moukhtar DA; Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt.

Spectrochim Acta A Mol Biomol Spectrosc ; 299: 122838, 2023 Oct 15.

Article em En | MEDLINE | ID: mdl-37187147

Assuntos

Finasterida; Hiperplasia Prostática; Humanos; Masculino; Tadalafila; Fluorescência; Hiperplasia Prostática/tratamento farmacológico; Cápsulas; Espectrometria de Fluorescência

Palavras-chave

Finasteride; Green chemistry; Synchronous fluorescence; Tadalafil

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Finasterida Limite: Humans / Male Idioma: En Revista: Spectrochim Acta A Mol Biomol Spectrosc Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google